Last33.92 -0.01 (-0.03%)
29.735 - 71.25
52 Week Range
Technical Indicators (Daily)
Is Adaptive Biotechnologies Corporation (NASDAQ:ADPT) a good place to invest some of your money right now? We can gain invaluable insight to help us answer that question by studying the investment tre...
Harlan Robins, Chief Scientific Officer at Adaptive Biotechnologies (NASDAQ:ADPT), made a large buy and sell of company shares on October 8, according to a new SEC filing. What Happened: A Form 4 fili...
Every investor in Adaptive Biotechnologies Corporation ( NASDAQ:ADPT ) should be aware of the most powerful shareholder......
Chad Cohen, Chief Financial Officer at Adaptive Biotechnologies (NASDAQ:ADPT), made a large buy and sell of company shares on October 6, according to a new SEC filing. What Happened: A Form 4 filing f...
SEATTLE, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune syst...
Disclaimer: The data contained in Super Surge website is not necessarily real-time nor accurate and may differ from the actual market data. Prices, volumes, ratios, charts and indicators are indicative and not appropriate for trading purposes. Super Surge doesn't bear any responsibility for any trading losses you might incur as a result of using this data.